109 related articles for article (PubMed ID: 29282361)
1. Influence of BCL2L11 polymorphism on osteonecrosis during treatment of childhood acute lymphoblastic leukemia.
Plesa M; Gagné V; Glisovic S; Younan M; Sharif-Askari B; Laverdière C; Alos N; Leclerc JM; Sallan SE; Neuberg D; Kutok JL; Silverman LB; Sinnett D; Krajinovic M
Pharmacogenomics J; 2019 Feb; 19(1):33-41. PubMed ID: 29282361
[TBL] [Abstract][Full Text] [Related]
2. Genes identified through genome-wide association studies of osteonecrosis in childhood acute lymphoblastic leukemia patients.
Gagné V; Aubry-Morin A; Plesa M; Abaji R; Petrykey K; St-Onge P; Beaulieu P; Laverdière C; Alos N; Leclerc JM; Sallan SE; Neuberg D; Kutok JL; Silverman LB; Sinnett D; Krajinovic M
Pharmacogenomics; 2019 Nov; 20(17):1189-1197. PubMed ID: 31686588
[No Abstract] [Full Text] [Related]
3. A
Zgheib NK; El-Khoury H; Maamari D; Basbous M; Saab R; Muwakkit SA
Per Med; 2021 Sep; 18(5):431-439. PubMed ID: 34406079
[TBL] [Abstract][Full Text] [Related]
4. Bim polymorphisms: influence on function and response to treatment in children with acute lymphoblastic leukemia.
Gagné V; Rousseau J; Labuda M; Sharif-Askari B; Brukner I; Laverdière C; Ceppi F; Sallan SE; Silverman LB; Neuberg D; Kutok JL; Sinnett D; Krajinovic M
Clin Cancer Res; 2013 Sep; 19(18):5240-9. PubMed ID: 23908358
[TBL] [Abstract][Full Text] [Related]
5. Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia.
Karol SE; Yang W; Van Driest SL; Chang TY; Kaste S; Bowton E; Basford M; Bastarache L; Roden DM; Denny JC; Larsen E; Winick N; Carroll WL; Cheng C; Pei D; Fernandez CA; Liu C; Smith C; Loh ML; Raetz EA; Hunger SP; Scheet P; Jeha S; Pui CH; Evans WE; Devidas M; Mattano LA; Relling MV
Blood; 2015 Oct; 126(15):1770-6. PubMed ID: 26265699
[TBL] [Abstract][Full Text] [Related]
6. A thymidylate synthase polymorphism is associated with increased risk for bone toxicity among children treated for acute lymphoblastic leukemia.
Finkelstein Y; Blonquist TM; Vijayanathan V; Stevenson KE; Neuberg DS; Silverman LB; Vrooman LM; Sallan SE; Cole PD
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27957785
[TBL] [Abstract][Full Text] [Related]
7. Bony morbidity in children treated for acute lymphoblastic leukemia.
Strauss AJ; Su JT; Dalton VM; Gelber RD; Sallan SE; Silverman LB
J Clin Oncol; 2001 Jun; 19(12):3066-72. PubMed ID: 11408503
[TBL] [Abstract][Full Text] [Related]
8. ALL and osteonecrosis.
Gaynon PS
Blood; 2015 Oct; 126(15):1734-5. PubMed ID: 26450951
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.
Kawedia JD; Kaste SC; Pei D; Panetta JC; Cai X; Cheng C; Neale G; Howard SC; Evans WE; Pui CH; Relling MV
Blood; 2011 Feb; 117(8):2340-7; quiz 2556. PubMed ID: 21148812
[TBL] [Abstract][Full Text] [Related]
10. Osteonecrosis in children with acute lymphoblastic leukemia: A report from Children's Cancer Hospital Egypt (CCHE).
Ali N; Gohar S; Zaky I; Elghoneimy A; Youssef S; Sameer G; Yassin D; Salem S; Magdi H; Sidhom I
Pediatr Blood Cancer; 2019 Jan; 66(1):e27440. PubMed ID: 30183135
[TBL] [Abstract][Full Text] [Related]
11. Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia.
den Hoed MA; Pluijm SM; te Winkel ML; de Groot-Kruseman HA; Fiocco M; Hoogerbrugge P; Leeuw JA; Bruin MC; van der Sluis IM; Bresters D; Lequin MH; Roos JC; Veerman AJ; Pieters R; van den Heuvel-Eibrink MM
Haematologica; 2015 Dec; 100(12):1564-70. PubMed ID: 26405155
[TBL] [Abstract][Full Text] [Related]
12. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
Mattano LA; Sather HN; Trigg ME; Nachman JB
J Clin Oncol; 2000 Sep; 18(18):3262-72. PubMed ID: 10986059
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the Relationship Between
Erdem M; Tüfekçi Ö; Kızıldağ S; Yılmaz Ş; Kızmazoğlu D; Eroğlu Filibeli B; Ören H
Turk J Haematol; 2019 Feb; 36(1):12-18. PubMed ID: 30251958
[TBL] [Abstract][Full Text] [Related]
14. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia.
Aricò M; Boccalatte MF; Silvestri D; Barisone E; Messina C; Chiesa R; Santoro N; Tamaro P; Lippi A; Gallisai D; Basso G; De Rossi G;
Haematologica; 2003 Jul; 88(7):747-53. PubMed ID: 12857552
[TBL] [Abstract][Full Text] [Related]
15. Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia.
te Winkel ML; Appel IM; Pieters R; van den Heuvel-Eibrink MM
Haematologica; 2008 Oct; 93(10):1570-4. PubMed ID: 18698082
[TBL] [Abstract][Full Text] [Related]
16. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia.
te Winkel ML; Pieters R; Hop WC; de Groot-Kruseman HA; Lequin MH; van der Sluis IM; Bökkerink JP; Leeuw JA; Bruin MC; Egeler RM; Veerman AJ; van den Heuvel-Eibrink MM
J Clin Oncol; 2011 Nov; 29(31):4143-50. PubMed ID: 21947829
[TBL] [Abstract][Full Text] [Related]
17. [Association between BIM gene and glucocorticoid resistance in children with acute lymphoblastic leukemia].
Xu JY; Luo JM
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Aug; 19(8):945-949. PubMed ID: 28774373
[TBL] [Abstract][Full Text] [Related]
18. Bloodstream infections exacerbate incidence and severity of symptomatic glucocorticoid-induced osteonecrosis.
Finch ER; Janke LJ; Smith CA; Karol SE; Pei D; Cheng C; Kaste SC; Inaba H; Pui CH; Wolf J; Relling MV
Pediatr Blood Cancer; 2019 Jun; 66(6):e27669. PubMed ID: 30758124
[TBL] [Abstract][Full Text] [Related]
19. Assessment of corticosteroid-induced osteonecrosis in children undergoing chemotherapy for acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.
Hyakuna N; Shimomura Y; Watanabe A; Taga T; Kikuta A; Matsushita T; Kogawa K; Kawakami C; Horikoshi Y; Iwai T; Okamoto Y; Tsurusawa M; Asami K;
J Pediatr Hematol Oncol; 2014 Jan; 36(1):22-9. PubMed ID: 24136019
[TBL] [Abstract][Full Text] [Related]
20. High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia.
Niinimäki RA; Harila-Saari AH; Jartti AE; Seuri RM; Riikonen PV; Pääkkö EL; Möttönen MI; Lanning M
J Clin Oncol; 2007 Apr; 25(12):1498-504. PubMed ID: 17442991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
